Top Markets
Coin of the day
Alliance Pharma plc Alliance Pharma plc

Alliance Pharma plc

APH
Rang in aandelen #13762
Alliance Pharma plc is a pharmaceutical firm with an expansive global reach,... Alliance Pharma plc is a pharmaceutical firm with an expansive global reach, conducting business across Europe, the Middle East, Africa, the Asia Pacific region, China, and the Americas. The company's core activities involve sourcing, promoting, and distributing a diverse array of consumer healthcare items and prescribed medications. It currently manages the marketing rights for approximately 80 different products within these categories. Additionally, its offerings extend to medical devices, dietary supplements, and cosmetic goods. Notable brands within its portfolio include Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen. Founded in 1996, Alliance Pharma plc maintains its corporate base in Chippenham, United Kingdom.
Aandeelprijs
$0.85814713
Laatst gesynchroniseerd: 2025-05-14
Marktkapitalisatie
$463.40M
Verandering (1 dag)
-2.52%
Verandering (1 jaar)
0.00%
Land
GB
Handel Alliance Pharma plc (APH)

Categorie

Winst voor Alliance Pharma plc (APH)
Winst in Dec 2024 TTM: $-18.14M
Volgens de meest recente financiële verslagen van Alliance Pharma plc bedraagt de huidige winst van het bedrijf $-18.14M. In 2023 behaalde het bedrijf een winst van $-62.12M, een daling ten opzichte van de winst van 2022, die $6.30M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Alliance Pharma plc van 2001 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
2026 (TTM) $-18.14M 0.00%
2024 $-18.14M -70.79%
2023 $-62.12M -1,085.97%
2022 $6.30M -74.33%
2021 $24.55M 37.95%
2020 $17.80M -56.82%
2019 $41.21M 41.89%
2018 $29.04M -24.24%
2017 $38.34M 39.81%
2016 $27.42M 22.57%
2015 $22.37M 41.38%
2014 $15.82M -20.44%
2013 $19.89M 13.43%
2012 $17.53M 5.47%
2011 $16.62M -17.03%
2010 $20.03M 115.66%
2009 $9.29M 162.51%
2008 $3.54M -155.33%
2007 $-6.40M -762.99%
2006 $964.73K -15.19%
2005 $1.14M -128.40%
2004 $-4.01M 3,427.78%
2002 $-113.53K -162.31%
2001 $182.20K 0.00%
Winst van vergelijkbare bedrijven of concurrenten